McKInney-based StatLab Medical Products has acquired Germany-based histology service and distribution company Histoserve GmbH as well as Diapath France SAS.
StatLab, a global developer and manufacturer of medical diagnostic supplies and equipment, said the moves mark “a significant step forward” in its European growth strategy, expanding its direct commercial presence to the top four European markets: France, Germany, Italy, and the U.K. StatLab said the deals position it among the few suppliers with fully direct access to Europe’s largest pathology markets, enabling closer customer relationships and expanded access to StatLab’s full product portfolio.
Terms of the two deals were not disclosed.
Founded by Wolfgang Jakobi in 2010 near Hannover, Germany, Histoserve has evolved into a comprehensive solutions provider for pathology labs, providing reliable reagents, innovative instrumentation through Diapath, and best-in-class post-sales support, StatLab said. Diapath made a strategic majority investment in Histoserve in 2021 to create a regional hub and direct market access in Germany. Histoserve has deep equipment service expertise and strong customer ties and will play a critical role in expanding market access to the entire StatLab portfolio in Europe’s largest market.
StatLab acquired the remaining stake in Diapath France—a joint venture formed in 2023 between Diapath and Jacques Hannaby to serve the direct laboratory market in France. StatLab said the additions strengthen its direct footprint and future scalability in France and Germany while complementing its already established presence in the U.K. and Italy, and provide the platform to create an industry leader across the four largest European markets and beyond.
Jakobi said the deal increases the company’s access to a broader portfolio.
“The evolution of the StatLab organization has been exciting to witness, and we’re proud to now be a full part of their differentiated solution as a result of the completed acquisition,” Jakobi said in a statement. “Our customers will gain access to a broader product portfolio, and together we’ll deliver a more unified customer experience, supporting growth with direct labs across Germany and Northern Europe.”
Diapath Managing Director Alberto Battistel said the acquisition boosts his company.
“We’re thrilled to officially welcome Histoserve and Diapath France into the StatLab family,” Battistel said. “Although we’ve collaborated with Wolfgang and Jacques for several years, fully integrating their businesses into our European strategic plan will further strengthen customer relationships and fuel additional growth.”
Don’t miss what’s next. Subscribe to Dallas Innovates.
Track Dallas-Fort Worth’s business and innovation landscape with our curated news in your inbox Tuesday-Thursday.
R E A D N E X T
McKinney-based StatLab Medical Products is scaling its global reach with a series of strategic moves, including acquisitions and expanded facilities, such as a new one in Arlington. CEO Sung-Dae Hong, who took the helm this time last year, brings decades of experience in driving growth and M&A.
The MotiliCap capsule system offers a non-invasive, high-tech way to assess how the gastrointestinal tract is functioning — giving clinicians advanced insights into digestive health and movement.
StatLab said the integration of Tarragona, Spain-based Myr equips StatLab to expand both its portfolio and its international footprint.
A team of UT Dallas computer scientists has partnered with Plano-based CorroHealth to introduce “reasoning” to the company’s LLM- and NLP-based coding automation technology. “The goal is to extract knowledge like a human would do it,” said UTD’s Dr. Gopal Gupta.
The Orlando-based home medical equipment provider said its new strategic warehouse facilities in Dallas and Los Angeles “will drastically reduce shipping times and improve fulfillment capabilities nationwide” as it seeks to “bridge the delivery gap” in vital medical products.